Reference | Juntunen2012 (10009)

Campylobacter coli isolates from finnish farrowing farms using aminopenicillins: High prevalence of blaOXA-61 and β-Lactamase production, but low MIC values.


Juntunen, Pekka; Heiska, Helmi; Hänninen, Marja Liisa (Finland)

Foodborne Pathogens and Disease (2012)

Reference


We investigated whether the therapeutic usage of aminopenicillins selects antimicrobial resistance in porcine C. coli isolates. Seven Finnish farrowing farms that treat piglets or sows with injectable aminopenicillins were selected for this study. Aminopenicillins were administered for the treatment of diarrhea or MMA (mastitis, metritis, agalactia) syndrome at 15mg/kg intramuscularly for 3–5 days. Twenty-six animals (seven sows and 19 piglets) received aminopenicillin therapy. Susceptibilities to ampicillin, ciprofloxacin, and erythromycin were determined either with the VetMIC or the agar dilution method (CLSI, 2002).

Individual faecal samples were taken from the rectum with Probact transport swabs ( Juntunen et al., 2010).

AST Method: Agar Dilution

Reference explicitly reports AST breakpoints: True

Reference reports using a MIC table: True

Is Excluded: False

Country Sub-Region Sub-Region Detail
Finland None None
ID Note Resolution

Factors


Title Host Host Production Stage Description ROs
Aminopenicillin use Swine Not Specified Farm Therapeutic usage of aminopenicillins for the treatment of diarrhea or MMA syndrome at 15mg/kg intramuscularly for 3–5 days (isolates taken 9–22 days after treatment). Aminopenicillin defined as either ampicillin (150 mg/L) or amoxicillin (150 mg/L). 3